Follow-up of aspirin-resistant patients with end-stage kidney disease


Kilickesmez K. O., Kocas C., Abaci O., Okcun B., Gorcin B., Gurmen T.

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.45, no.4, pp.1097-1102, 2013 (SCI-Expanded) identifier identifier identifier

Abstract

Aspirin resistance is defined by platelet function testing and presumed clinical unresponsiveness to aspirin. Aspirin-resistant patients are at a greater risk of clinically important adverse cardiovascular events. We aimed to investigate whether end-stage renal disease patients with aspirin resistance are at increased risk for long-term major adverse clinical events.